sur AMOEBA (EPA:ALMIB)
Amoéba Wins Gold at SIVAL for Biocontrol Innovation
Amoéba, a French greentech company, was awarded the gold medal at the SIVAL Innovation 2026 in Angers, France, for its biocontrol solution AXPERA. This recognition highlights their innovative approach to plant health, particularly against fungal diseases. Jean-François Doucet, CEO, expressed pride in this achievement, complementing past accolades like the Bernard Blum Award.
Amoéba has made strategic alliances, notably with Koppert, gaining exclusive distribution rights across Europe and the US for five years. They aim to launch the rebranded TIAGAN solution in nine European countries, pending regulatory approvals, targeting vineyards and vegetable crops.
In 2025, Amoéba saw considerable regulatory success, with European and US approvals for their biocontrol products. This, combined with a partnership with Syngenta, positions them well for market expansion. CNN's coverage in 2026 further underscores their innovative capabilities.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de AMOEBA